X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
ophthalmology (30) 30
female (29) 29
male (29) 29
aged (28) 28
index medicus (28) 28
tomography, optical coherence (20) 20
aged, 80 and over (18) 18
fluorescein angiography (17) 17
middle aged (17) 17
macular degeneration (16) 16
retrospective studies (15) 15
visual acuity - physiology (15) 15
optical coherence tomography (14) 14
medical imaging (13) 13
abridged index medicus (12) 12
prospective studies (12) 12
adult (10) 10
age (8) 8
cross-sectional studies (8) 8
intravitreal injections (8) 8
photography (8) 8
polypoidal choroidal vasculopathy (8) 8
visual acuity (8) 8
follow-up studies (7) 7
prevalence (7) 7
age-related macular degeneration (6) 6
coloring agents (6) 6
diabetic retinopathy (6) 6
indocyanine green (6) 6
lasers (6) 6
medical colleges (6) 6
patients (6) 6
ranibizumab (6) 6
tomography, optical coherence - methods (6) 6
vascular endothelial growth factor a - antagonists & inhibitors (6) 6
visual-acuity (6) 6
wet macular degeneration - diagnosis (6) 6
angiogenesis inhibitors - therapeutic use (5) 5
association (5) 5
fundus oculi (5) 5
photodynamic therapy (5) 5
physiological aspects (5) 5
reticular pseudodrusen (5) 5
retina (5) 5
retinal drusen - diagnosis (5) 5
retinopathy (5) 5
standard deviation (5) 5
studies (5) 5
tomography (5) 5
vascular endothelial growth factor (5) 5
vitrectomy (5) 5
wet macular degeneration - drug therapy (5) 5
aflibercept (4) 4
coherence tomography (4) 4
diabetic macular edema (4) 4
disease (4) 4
endothelial growth-factor (4) 4
eye diseases (4) 4
eyes (4) 4
fundus autofluorescence (4) 4
genotype (4) 4
living human eye (4) 4
macula lutea - pathology (4) 4
macular degeneration - diagnosis (4) 4
medicine & public health (4) 4
neovascularization (4) 4
pathology (4) 4
prognosis (4) 4
subretinal drusenoid deposits (4) 4
thickness (4) 4
time factors (4) 4
ultrahigh-resolution (4) 4
visual field tests (4) 4
adaptive optics (3) 3
analysis (3) 3
bevacizumab (3) 3
central serous chorioretinopathy (3) 3
choroid - blood supply (3) 3
clinicopathological correlation (3) 3
eyes & eyesight (3) 3
features (3) 3
genetic structures (3) 3
geographic atrophy (3) 3
high-risk (3) 3
hyperreflective foci (3) 3
imaging, three-dimensional (3) 3
internal limiting membrane (3) 3
japan - epidemiology (3) 3
multidisciplinary sciences (3) 3
ophthalmoscopy (3) 3
ophthalmoscopy - methods (3) 3
photoreceptor cells, vertebrate - pathology (3) 3
receptors, vascular endothelial growth factor - administration & dosage (3) 3
receptors, vascular endothelial growth factor - therapeutic use (3) 3
recombinant fusion proteins - administration & dosage (3) 3
recombinant fusion proteins - therapeutic use (3) 3
reproducibility of results (3) 3
retina - pathology (3) 3
retina - physiopathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 3620 - 7
Intravitreal injections of anti-vascular endothelial growth factor agents such as ranibizumab and aflibercept are the first-line treatment for neovascular... 
VISUAL-ACUITY | RECURRENCE | GROWTH-FACTOR THERAPY | MULTIDISCIPLINARY SCIENCES | RANIBIZUMAB TREATMENT | Macular degeneration | Vascular diseases | Vision | Retina | Vascular endothelial growth factor | Patients | Age
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 05/2019, Volume 103, Issue 5, pp. 617 - 622
Background/aimsTo evaluate the 5-year visual and anatomical outcomes after anti-vascular endothelial growth factor (VEGF) therapy alone or in combination with... 
neovascularisation | treatment lasers | retina | macula | treatment medical | INTRAVITREAL INJECTIONS | MONOTHERAPY | EFFICACY | SAFETY | OPHTHALMOLOGY | MACULAR DEGENERATION | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Ophthalmology. Retina, 11/2018, Volume 2, Issue 11, p. 1118
To explore novel prognostic factors associated with visual function and number of anti-vascular endothelial growth factor (VEGF) treatments in eyes with active... 
Journal Article
Retina, ISSN 0275-004X, 11/2017, Volume 37, Issue 11, pp. 2069 - 2077
Journal Article
Journal Article
Retina, ISSN 0275-004X, 07/2017, Volume 37, Issue 7, pp. 1320 - 1328
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 01/2017, Volume 58, Issue 1, pp. 292 - 298
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 9/2015, Volume 253, Issue 9, pp. 1471 - 1477
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2015, Volume 159, Issue 5, pp. 853 - 860.e1
Journal Article